| Previous close | 0.4800 |
| Open | 0.4800 |
| Bid | 0.0500 |
| Ask | 0.0000 |
| Strike | 7.50 |
| Expiry date | 2024-05-17 |
| Day's range | 0.4800 - 0.4800 |
| Contract range | N/A |
| Volume | |
| Open interest | 31 |
GlobeNewswireAvid Bioservices to Participate at Upcoming Investor Conferences
TUSTIN, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will participate at two upcoming investor conferences. Nick Green, president and chief executive officer, will be the featured speaker in a fireside chat
Insider MonkeyHow Novo-Catalent Deal Affects Halozyme (HALO)?
Laughing Water Capital, an investment management company, released its first-quarter 2024 investor letter. A copy of the same can be downloaded here. In the first quarter, investment in the fund returned 8.4% after all fees and expenses compared to 10.6% and 5.2% returns for the SP500TR and R2000 during the quarter, respectively. In addition, you […]
- Thomson Reuters StreetEvents
Q3 2024 Avid Bioservices Inc Earnings Call
Q3 2024 Avid Bioservices Inc Earnings Call
